These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 19630827)

  • 1. Inflammatory mechanisms in atherosclerosis.
    Hansson GK
    J Thromb Haemost; 2009 Jul; 7 Suppl 1():328-31. PubMed ID: 19630827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation and atherosclerosis.
    Hansson GK; Robertson AK; Söderberg-Nauclér C
    Annu Rev Pathol; 2006; 1():297-329. PubMed ID: 18039117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherosclerosis--an immune disease: The Anitschkov Lecture 2007.
    Hansson GK
    Atherosclerosis; 2009 Jan; 202(1):2-10. PubMed ID: 18951547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on lipids, inflammation and atherothrombosis.
    Badimon L; Storey RF; Vilahur G
    Thromb Haemost; 2011 May; 105 Suppl 1():S34-42. PubMed ID: 21479344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atherosclerosis as an inflammatory disease.
    Tuttolomondo A; Di Raimondo D; Pecoraro R; Arnao V; Pinto A; Licata G
    Curr Pharm Des; 2012; 18(28):4266-88. PubMed ID: 22390643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The inflammatory processes in atherogenesis].
    Cichoń N; Lach D; Dziedzic A; Bijak M; Saluk J
    Pol Merkur Lekarski; 2017 Mar; 42(249):125-128. PubMed ID: 28333905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immune factors in atherosclerosis].
    Pasqui AL; Bova G; Maffei S; Auteri A
    Ann Ital Med Int; 2005; 20(2):81-9. PubMed ID: 16052840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunology of atherosclerosis.
    Gisterå A; Hansson GK
    Nat Rev Nephrol; 2017 Jun; 13(6):368-380. PubMed ID: 28392564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thematic review series: the immune system and atherogenesis. Molecular mechanisms regulating monocyte recruitment in atherosclerosis.
    Quehenberger O
    J Lipid Res; 2005 Aug; 46(8):1582-90. PubMed ID: 15961784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory cell recruitment in cardiovascular disease: murine models and potential clinical applications.
    McNeill E; Channon KM; Greaves DR
    Clin Sci (Lond); 2010 Mar; 118(11):641-55. PubMed ID: 20210786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocytes in atherosclerosis.
    Wigren M; Nilsson J; Kolbus D
    Clin Chim Acta; 2012 Oct; 413(19-20):1562-8. PubMed ID: 22565046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokines: inflammatory mediators of atherosclerosis.
    Liehn EA; Zernecke A; Postea O; Weber C
    Arch Physiol Biochem; 2006; 112(4-5):229-38. PubMed ID: 17178596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone Deacetylase 9 Activates IKK to Regulate Atherosclerotic Plaque Vulnerability.
    Asare Y; Campbell-James TA; Bokov Y; Yu LL; Prestel M; El Bounkari O; Roth S; Megens RTA; Straub T; Thomas K; Yan G; Schneider M; Ziesch N; Tiedt S; Silvestre-Roig C; Braster Q; Huang Y; Schneider M; Malik R; Haffner C; Liesz A; Soehnlein O; Bernhagen J; Dichgans M
    Circ Res; 2020 Aug; 127(6):811-823. PubMed ID: 32546048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated platelets promote increased monocyte expression of CXCR5 through prostaglandin E2-related mechanisms and enhance the anti-inflammatory effects of CXCL13.
    Halvorsen B; Smedbakken LM; Michelsen AE; Skjelland M; Bjerkeli V; Sagen EL; Taskén K; Bendz B; Gullestad L; Holm S; Biessen EA; Aukrust P
    Atherosclerosis; 2014 Jun; 234(2):352-9. PubMed ID: 24732574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atherosclerosis: a classic inflammatory disease.
    Anogeianaki A; Angelucci D; Cianchetti E; D'Alessandro M; Maccauro G; Saggini A; Salini V; Caraffa A; Tete S; Conti F; Tripodi D; Shaik-Dasthagirisaheb YB
    Int J Immunopathol Pharmacol; 2011; 24(4):817-25. PubMed ID: 22230389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture.
    Boyle JJ
    Curr Vasc Pharmacol; 2005 Jan; 3(1):63-8. PubMed ID: 15638783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging biomarkers and intervention targets for immune-modulation of atherosclerosis - a review of the experimental evidence.
    Björkbacka H; Fredrikson GN; Nilsson J
    Atherosclerosis; 2013 Mar; 227(1):9-17. PubMed ID: 23177975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of damage- and pathogen-associated molecular patterns in inflammation-mediated vulnerability of atherosclerotic plaques.
    Rai V; Agrawal DK
    Can J Physiol Pharmacol; 2017 Oct; 95(10):1245-1253. PubMed ID: 28746820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines in atherosclerosis: pathogenic and regulatory pathways.
    Tedgui A; Mallat Z
    Physiol Rev; 2006 Apr; 86(2):515-81. PubMed ID: 16601268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atherosclerosis and arteriitis: implications for therapy of cardiovascular disease].
    Galle J
    Herz; 2004 Feb; 29(1):4-11. PubMed ID: 14968336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.